TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence

CompletedOBSERVATIONAL
Enrollment

418

Participants

Timeline

Start Date

June 17, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
DiabetesDiabetic FootDiabetic Foot UlcerDiabetic WoundDiabetic
Interventions
OTHER

Observational

no intervention

Trial Locations (6)

25261

University of Pittsburgh, Pittsburgh

33126

University of Miami, Miami

46202

Indiana University, Indianapolis

48109

University of Michigan, Ann Arbor

94143

University of California - San Francisco, San Francisco

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

Indiana University

OTHER

collaborator

Stanford University

OTHER

collaborator

University of Miami

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Michigan

OTHER

NCT04558775 - TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence | Biotech Hunter | Biotech Hunter